MiR-100 is a predictor of endocrine responsiveness and prognosis in patients with operable luminal breast cancer

Purpose Overexpression of miR-100 in stem cells derived from basal-like breast cancers causes loss of stemness, induction of luminal breast cancer markers and response to endocrine therapy. We, therefore, explored miR-100 as a novel biomarker in patients with luminal breast cancer.Methods miR-100 ex...

Full description

Bibliographic Details
Main Authors: Danilo Galizia, Anna Sapino, Filippo Montemurro, Elena Geuna, Annalisa Petrelli, Sara Erika Bellomo, Ivana Sarotto, Franziska Kubatzki, Paola Sgandurra, Furio Maggiorotto, Maria Rosaria Di Virgilio, Riccardo Ponzone, Anna Maria Nuzzo, Enzo Medico, Umberto Miglio, Enrico Berrino, Tiziana Venesio, Salvatore Ribisi, Paolo Provero, Silvia Giordano
Format: Article
Language:English
Published: Elsevier 2020-10-01
Series:ESMO Open
Online Access:https://esmoopen.bmj.com/content/5/5/e000937.full